J. Safra Sarasin Holding AG trimmed its position in Xylem Inc. (NYSE:XYL - Free Report) by 5.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 113,736 shares of the industrial products company's stock after selling 6,586 shares during the quarter. J. Safra Sarasin Holding AG's holdings in Xylem were worth $14,713,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the business. Valley National Advisers Inc. lifted its holdings in Xylem by 84.9% in the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after buying an additional 101 shares during the period. Perkins Coie Trust Co bought a new stake in shares of Xylem during the 1st quarter valued at $27,000. Maseco LLP acquired a new position in shares of Xylem in the 2nd quarter valued at $31,000. Center for Financial Planning Inc. boosted its position in shares of Xylem by 52.0% in the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after purchasing an additional 91 shares during the last quarter. Finally, ST Germain D J Co. Inc. lifted its stake in Xylem by 950.0% in the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock valued at $33,000 after buying an additional 228 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.
Insider Activity at Xylem
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer directly owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.27% of the stock is currently owned by corporate insiders.
Xylem Stock Performance
XYL opened at $149.02 on Friday. The company has a market capitalization of $36.27 billion, a price-to-earnings ratio of 38.71, a P/E/G ratio of 2.56 and a beta of 1.13. The business's 50-day moving average price is $141.61 and its two-hundred day moving average price is $129.23. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $149.93. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same period last year, the company earned $1.09 earnings per share. Xylem's quarterly revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Equities analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem's payout ratio is 41.56%.
Analyst Ratings Changes
A number of brokerages recently issued reports on XYL. Citigroup restated a "buy" rating and set a $152.00 price objective (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Stifel Nicolaus lifted their target price on Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Cowen reaffirmed a "hold" rating on shares of Xylem in a research report on Tuesday, August 26th. Finally, Zacks Research upgraded Xylem from a "hold" rating to a "strong-buy" rating in a report on Monday, September 22nd. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $152.33.
Read Our Latest Research Report on XYL
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.